Cell, gene therapy manufacturing takes center stage as Novartis, Amazon join forces
Tech giants have penetrated the realm of healthcare. Meanwhile, the biopharmaceutical industry has embraced the promise of digital drug development and medicine as it ushers in the era of telemedicine, wearables, cloud computing, machine learning and artificial intelligence. Novartis, which was one of the pioneering large drugmakers to hire a chief digital/technology officer in 2017, has now tied up with the widely used cloud platform Amazon Web Services to streamline its manufacturing, supply chain, and delivery operations.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.